TAG:
laboratory executive
Innovative Approach Promises Integration of Clinical Lab Data
CEO SUMMARY: Any laboratory executive with several years in the business has confronted the limitations of laboratory information system (LIS) software. For a variety of reasons, LIS software seldom delivers the full range of benefits and cost-effectiveness sought by laboratories. But in …
Lab Industry Briefs
MONOLAYER PAP SMEAR TEST In travels to laboratories around the United States, THE DARK REPORT is getting interesting, but anecdotal, feedback about Cytyc Corp.’s ThinPrep® monolayer Pap smear test. Pathologists and laboratory directors are noticing two perceived benefits …
“August 25, 1997 Intelligence: Late Breaking Lab News”
Meris Laboratories continues to be a turnaround challenge. The company announced on August 4 that CEO and President Denis Simon had resigned. Appointed by the board on March 25, Simon stayed less than 18 weeks in the position. Like several other California labs, the San Jose-based co…
Clinical Lab Industry A Mature Marketplace
In our role as the lab industry’s management “futurist” we spend a lot of time pondering the meaning of individual events in cities throughout the United States. One common trait of successful organizations is their ability to accurately translate such events into a strategic plan which correct…
Joint Venture In Phoenix To Be Copied Elsewhere
CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…
Big Hospital-PPM Alliance Announced For New York
CEO SUMMARY: This alliance involves PhyCor and the New York and Presbyterian Hospitals Care Network. Like the MedPartners/Tenet deal in California reported in our last issue, this joint venture will have far-reaching impact upon the local healthcare marketplace it serves. H…
Probe of Columbia/HCA Generates Indictments
CEO SUMMARY: Hospital laboratory executives should pay close attention to how federal prosecutors develop their case against Columbia/HCA. Earlier “Labscam” settlements with commercial laboratories and hospital laboratory billing practices centered around restitution and fines for imp…
Corning Stock Price Skyrockets Since Spin-Off Of Corning Labs
STOCK PRICES of Corning Incorporated have climbed since the divestiture on January 1, 1997 of Corning Clinical Laboratories and Corning Life Sciences into Quest Diagnostics Incorporated and Covance, Inc., respectively. During 1995 a…
Do You Want To Follow Or Lead?
How many of our clients are ready to lead the industry? This issue of THE DARK REPORT provides you with an opportunity to move ahead of your competitors and gain a critical advantage. I am referring to the emergence of physician practice management (PPM) companies. …
3 Blood Brothers Differ On Surcharge Strategies
CEO SUMMARY: United we stand, divided we fall. On the issue of laboratory test surcharge repeal in New York, the three national labs took independent positions. Was the clinical industry served by this lack of unanimity? More importantly, do the actions of two of these national laboratori…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.